Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
Background
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
Items 801–900 of 1,000
PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication
Geletu, M., Taha, Z., Gunning, P. T., & Raptis, L. H. (2019) · Cancers · doi:10.3390/cancers11020167 · Cited by 3
Mori, C., Valdivieso, Á. G., Clauzure, M., Massip-Copiz, M. M., Aguilar, M. Á., Cafferata, E. G. A., & Santa-Coloma, T. A. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108375 · Cited by 3
Surface‐enhanced Raman imaging of intact cancer cell membrane on a rough aluminum substrate
Ambardar, S., Binder, G. A., Huynh, P. K., Nguyen, D. H., Hrim, H., Le, T., & Voronine, D. V. (2023) · Journal of Raman Spectroscopy · doi:10.1002/jrs.6562 · Cited by 3
Kampke, E. H., Barroso, M. E. D. S., Escouto, L. D. S., Covre, L. P., Gava, A. L., Campagnaro, B. P., Kuster, R. M., & Meyrelles, S. S. (2025) · Antioxidants · doi:10.3390/antiox14070856 · Cited by 2
“Phorbol esters—bioactive compounds identified in E. tirucalli —are well-known PKC activators, especially of conventional isoforms such as PKC-α and PKC-β , and have been widely used as pharmacological tools to activate PKC in various tissues [57,58].”
Gałuszka, A., Łopuszyński, W., Kurowska, P., Kotarska, K., Rak, A., & Pawlicki, P. (2025) · Reproductive Biology · doi:10.1016/j.repbio.2025.101052 · Cited by 2
Luo, Y., Gao, A., Zhou, X., Hu, X., Chang, S., Liu, L., Zhang, L., Gui, Z., Yan, X., Huang, X., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02999 · Cited by 2
Mashrur, M. N., Sami, M. R. S., Islam, O., Mahfuz, S., Biswas, K., Islam, E., & Akhand, M. R. N. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100536 · Cited by 2
Membrane‐Surface Anchoring of Charged Diacylglycerol‐Lactones Correlates with Biological Activities
Raifman, O., Kolusheva, S., Kazzouli, S. E., Sigano, D. M., Kedei, N., Lewin, N. E., López‐Nicolás, R., Ortiz‐Espin, A., Gómez-Fernández, J. C., Blumberg, P. M., et al. (2010) · ChemBioChem · doi:10.1002/cbic.201000343 · Cited by 2
Simple fluorescence-based detection of protein kinase A activity using a molecular beacon probe
Ma, C., Lv, X., Wang, K., Jin, S., Liu, H., Wu, K., & Zeng, W. (2017) · Bioengineered · doi:10.1080/21655979.2017.1338219 · Cited by 2
Tang, H., Li, X., & Yang, R. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7092 · Cited by 2
“It has been reported that the PKC serine-threonine kinases are involved in different cellular processes and signal transduction pathways, which regulate cell proliferation, differentiation, apoptosis and migration (32-36).”
BackgroundAntiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure)
Ning, Q., Wu, T., Su, H.-B., Ma, K., Qi, J., Ni, M., & Wu, D. (2019) · Springer eBooks · doi:10.1007/978-94-024-1603-9_5 · Cited by 2
Alexander, P. M., Kucera, G. L., Pladna, K. M., & Pardee, T. S. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100780 · Cited by 2
Vanni, E., Lindner, K., Gavin, A., & Montessuit, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-42072-7 · Cited by 2
In silico identification of differentially expressed microRNAs in thyroid cancer
Çağlar, H. O., Aytatlı, A., & Karataş, Ö. F. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201306 · Cited by 3
Leopold, M., Sanchez, P. B. M., Krizanac, M., Štancl, P., Karlić, R., Prabutzki, P., Parafianczuk, V., Schiller, J., Asimakopoulos, A., Engel, K. M., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159574 · Cited by 2
Ntsethe, A., Dludla, P. V., & Nkambule, B. B. (2025) · Biomedicines · doi:10.3390/biomedicines13030741 · Cited by 2
“Phorbol 12-myristate 13-acetate (PMA) activates the protein kinase C (PKC) pathway, specifically the classical PKC isoforms (PKC α , PKC β , and PKC γ ) by mimicking the action of diacylglycerol (DAG), a second messenger generated during BCR signaling [20].”
Phorbol Esters and Diacylglycerol: The PKC Activators
Blumberg, P. M., Kedei, N., Lewin, N. E., Yang, D., Tao, J., Telek, A., & Géczy, T. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_3 · Cited by 5
Diacylglycerol Signaling: The C1 Domain, Generation of DAG, and Termination of Signals
Mérida, I., Carrasco, S., & Ávila‐Flores, A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_4 · Cited by 5
“However, and probably reflecting the complex roles of DAG-regulated molecules in cancer (Griner and Kazanietz 2007), DGK are reported to act both as tumor suppressors and as positive regulators of survival and proliferation in transformed cells (Filigheddu et al.”
BackgroundRegulation of PKC by Protein–Protein Interactions in Cancer
Kim, J., & Mochly‐Rosen, D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_5 · Cited by 2
Donovan, A. J., Lansu, K., Williams, J. G., Denning, M. F., & Gentile, S. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.077966 · Cited by 2
“They are subdivided according to their mechanism of activation: conventional PKCs ( , , and ) that are activated by Ca2 and diacylglycerol (DAG), novel PKCs ( , , , and ) that are activated by DAG, and atypical PKCs ( , , and ) that are Ca2 - and DAGindependent (Spitaler and Cantrell, 2004; Griner and Kazanietz, 2007).”
BackgroundPKCδ as a Target for Chemotherapeutic Drugs
Brodie, C., & Lomonaco, S. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_22 · Cited by 2
Signaling pathways that overactivate metabolism and drive neoplasia, in rhabdomyosarcoma
Tselios, C. P., & Lambrou, G. Ι. (2019) · Journal of Research and Practice on the Musculoskeletal System · doi:10.22540/jrpms-03-017 · Cited by 2
“Molecular cancer research: MCR 2010;8(5):677-90.”
Ganapathy, S., Liu, J., Yu, T., Xiong, R., Zhang, Q., Makriyannis, A., & Chen, C. (2022) · Aging · doi:10.18632/aging.203917 · Cited by 3
“These two PLC products in turn activate several intracellular kinases, including PKC [28, 29].”
BackgroundTakahashi, D., Yonezawa, K., Okizaki, Y., Caaveiro, J. M. M., Ueda, T., Shimada, A., Sakane, F., & Shimizu, N. (2022) · Protein Science · doi:10.1002/pro.4365 · Cited by 2
A tale of three PKCs: Epsilon emerges as a driver of pre-neoplastic phenotypes
Knudsen, K. E. (2011) · Cell Cycle · doi:10.4161/cc.10.3.14740 · Cited by 2
Regulación del gen PEIG-1/GPRC5A por 12-O-tetradecanoilforbol-13-acetato
Mori, C. (2020) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/107365 · Cited by 2
Zhao, Z. (2008) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.2697 · Cited by 2
Ammoury, R., Tahtouh, R., Mahfouz, N., Doumit, R., Khalil, C., & Hilal, G. (2021) · Y HOC TP HO CHI MINH · doi:10.32895/ump.mpr.5.4.3 · Cited by 1
PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth
Haedo, M. N. C., Albuja, J. A. D., Camarero, S., Cayrol, F., Sterle, H., Debernardi, M., Perona, M., Sabán, M., Ernst, G., Mendez, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212158 · Cited by 1
“Phosphatidylserine can regulate the activity of the three groups [18–20].”
Akamatsu, Y., Onishi, M., Nagano, T., Oka, M., Kamada, S., & Iwasaki, T. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf040 · Cited by 1
Mansour, H. M., & El-Khatib, A. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32852-7.00003-6 · Cited by 2
Vav3, a potential diagnostic and prognostic marker of diabetes, regulates glycolipid metabolism
Wang, C., Wei, M., Wang, Y., He, H., Huang, C., Liu, D., & Qiao, Y. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101429 · Cited by 2
Tesfaye, S., Birkel, L., Bandaru, S. S. M., Barrera-Adame, D. A., Eichelbaum, M., Lulekal, E., Asres, K., Engidawork, E., Schulze, C., Win, N. N., et al. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107090 · Cited by 1
Molecular Determinants for the Binding Mode of Alkylphosphocholines in the C2 Domain of PKCα
de Sá, M. M., & Rangel‐Yagui, C. D. O. (2015) · Molecular Informatics · doi:10.1002/minf.201400104 · Cited by 4
Protein Kinases and Caspases: Bidirectional Interactions in Apoptosis
Zukowski, S. A., & Litchfield, D. W. (2015) · Wiley eBooks · doi:10.1002/9783527683031.ch4 · Cited by 1
Borah, R., Mamidi, N., Panda, S., Gorai, S., Pathak, S. K., & Manna, D. (2015) · Molecular BioSystems · doi:10.1039/c5mb00100e · Cited by 1
Vitamin D and breast cancer: Molecular communications
Lee, H. J. (2011) · Journal of the Korean Society for Applied Biological Chemistry · doi:10.1007/bf03253171 · Cited by 1
“regulates cell growth, apoptosis, differentiation, cell migration, and carcinogenesis in different types of cells [Teicher, 2006; Griner and Kazanietz, 2007].”
BackgroundHafeez, B. B., Meske, L. M., Singh, A. K., Singh, A., Zhong, W., Powers, P. A., John, M. C., Griep, A. E., & Verma, A. K. (2016) · Oncotarget · doi:10.18632/oncotarget.8850 · Cited by 1
Hautala, L. C., Koistinen, R., & Koistinen, H. K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.020 · Cited by 2
“Interestingly, the levels of phosphorylated PDK1, which participates in PKC maturation, were somewhat reduced in glycodelin-producing cells (0.58-fold as compared to control cells, p N 0.05, n = 3 for both).”
BackgroundInfluentialClinical Proteomics and Molecular Pathology
Liotta, L. A., Davis, J. B., Couch, R. D., Fredolini, C., Zhou, W., Petricoin, E. F., & Espina, V. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00009-2 · Cited by 1
Omics approach towards understanding the function of bioactive lipids in osteosarcoma
Roy, J. (2017) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign) · Cited by 1
The FYN-TRAF3IP2 gene fusion drives oncogenic NF-κB signaling in peripheral T cell lymphoma
Kim, C. S. (2020) · doi:10.7916/d8-5w9r-w324 · Cited by 1
Jatropha: A Potential Bioresource for Biofuel Production
Sharma, A., & Arya, S. K. (2020) · Biofuel and biorefinery technologies · doi:10.1007/978-3-030-53933-7_15 · Cited by 1
Disturbing intracellular replication of Helicobacter Pylori by Sorafenib treatment in-vitro
Roshdy, T. M., Saleh, S. A., Abass, N. H., Bassiouny, K., & Khalil, H. (2021) · African Journal of Biological Sciences · doi:10.21608/ajbs.2021.107592.1026 · Cited by 1
“mitogen-activated protein kinase (MAPK) (Bhalla et al., 2002; Griner and Kazanietz, 2007; Koivunen et al., 2006).”
BackgroundRuel, N. M., & Hammond, J. R. (2025) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2025.130765 · Cited by 1
Noor, R. E., Islam, S., Smalley, T. B., Mizgalska, K., Eschenfelder, M. J., Keramisanou, D., Astalos, A. J., Leahy, J. W., Guida, W. C., Karolak, A. M., et al. (2025) · Biophysica · doi:10.3390/biophysica5030036 · Cited by 1
The Protein Kinase C Family: Key Regulators Bridging Signaling Pathways in Skin and Tumor Epithelia
Breitkreutz, D., Braiman, L., Schneider‐Daum, N., & Tennenbaum, T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6382-6_8 · Cited by 1
Polarity and endocytic traffic in the mammalian cell
Bugyei, F. K. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Atypical PKCs as Targets for Cancer Therapy
Justilien, V., & Fields, A. P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_23 · Cited by 1
Synthesis of Six-Membered Rings and Inhibitors of Protein Kinases
Kiriazis, A. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 1
Batarseh, A. M. (2010) · DigitalGeorgetown (Georgetown University Library) · Cited by 1
Zeidler, J. D. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2012.tde-23042013-105402 · Cited by 7
Role of membranes in mammalian stress response: sensing, lipid signals and adaptation
Balogh, G. E. (2011) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Gunawan, F. (2015) · TSpace (University of Toronto) · Cited by 3
Casado‐Medrano, V., Baker, M. J., Cooke, M., & Kazanietz, M. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.28.359588 · Cited by 2
“The accepted general paradigm of PKC activation is that DAG generated upon stimulation of membrane receptors promotes cPKC and nPKC translocation to the plasma membrane, inducing a conformational change that leads to phosphorylation of specific PKC substrates (1-4).”
BackgroundMethodInfluentialSelf-citationDesign, Synthesis and Characterization of Novel sn-1 Heterocyclic DAGlactones as PKCe ActivatorsPreprint
Elhalem, E., Bellomo, A., Cooke, M., Scravaglieri, A., Pearce, L. V., Peach, M. L., Gandolfi-Donadío, L., Kazanietz, M. G., & Comin, M. J. (2020) · ChemRxiv · doi:10.26434/chemrxiv.13107194 · Cited by 1
Self-citationSalama, M., Liu, M., Clarke, C. J., Espaillat, M. P., Haley, J. D., Jin, T., Wang, D., Obeid, L. M., & Hannun, Y. A. (2019) · Oncogene · doi:10.1038/s41388-019-1019-8 · Cited by 1
Helou, M. E. (2017) · theses.fr (ABES) · doi:10.70675/0c7d676dz64a3z4641zb8cbzd99a75ef2126 · Cited by 1
PRKCa: Identification of a Novel Downstream Target of WT1
Jones, D. (2013) · Digital Commons-TMC (Texas Medical Center)
Nurmi, S. M. (2008) · Työväentutkimus Vuosikirja
de Sá, M. M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2014.tde-27052015-113949
The role of 8q amplification and microRNAs in prostate cancer
Jalava, S. E. (2012) · Tampere University Institutional Repository (Tampere University)
Pathophysiology of Protein Kinase C Isozymes in Chronic Lymphocytic Leukaemia
Cawley, J. C., & Joseph, R. E. (2012) · InTech eBooks · doi:10.5772/28964
“For example, high levels of PKC expression are associated with breast, prostrate, gastric and brain cancers (Griner & Kazanietz, 2007;Michie & Nakagawa, 2005) whilst low levels of PKC expression are associated with cancers of epithelium, pancreas, colon and CLL (Abrams, et al., 2007;Alvaro, et al.,…”
BackgroundNF-kappaB in skin immune homeostasis and cancer development
Ulvmar, M. H. (2009) · Figshare
Salotti, J. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2009.tde-06082009-150519 · Cited by 1
PKC Epsilon: A Novel Oncogenic Player in Prostate Cancer
Garg, R. (2013) · Defense Technical Information Center (DTIC) · doi:10.21236/ada592838
Kleiman, E. (2009) · Digital Commons - University of South Florida (University of South Florida)
THE C1 DOMAIN IN CANCER SIGNALING MOLECULES: REGULATION BY LIPIDS AND PROTEIN-PROTEIN INTERACTIONS
Wang, H. (2010) · ScholarlyCommons (University of Pennsylvania)
The Regulation of Alternative Splicing by Oncogenic Signaling Pathways.
Shultz, J. C. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/s89v-h307
Optimising intratumoural treatment of head and neck squamous cell carcinoma mouse models with EBC-46
Barnett, C. M. E. (2015) · The University of Queensland · doi:10.14264/uql.2015.895
“This confers hydrophobic properties which then facilitates PKC docking onto membranes and interacting with respective substrates before they are degraded by proteolytic enzymes [8].”
BackgroundInfluentialRoles of protein kinase C in cell death and breast cancer
Cornmark, L. (2013) · Lund University Publications (Lund University)
ERBB4 mutations in cancer and amyotrophic lateral sclerosis
Kurppa, K. J. (2014) · UTUPub (University of Turku) · Cited by 1
Oxidative stress and inflammation as a response to glucose exposure and dialysis
Bryland, A. (2013) · Lund University Publications (Lund University)
Differental regulation of Moraxella catarrhalis-induced IL-8 response by PKC isoforms
Slevogt, H., Maqami, L. Q., Vardarova, K., Hocke, C., Eitel, J., Schmeck, B., Weimann, A., Opitz, B., Hippenstiel, S., Suttorp, N., et al. (2008) · Pneumologie · doi:10.1055/s-2008-1074355
“The PKC family has long been known to play pivotal roles in controlling inflammation, cell growth, differentiation and apoptosis by regulating the activity of transcription factors such as NF-κB [19, 46].”
BackgroundΑναστολή της PKC-ε και μηχανισμοί ογκογένεσης στο ΚΝΣ
Κολιού, Ξ. (2012) · doi:10.12681/eadd/27973
Investigating the Therapeutic Efficacy of a Novel Inhibitor GAP-107B8 on Ovarian Cancer Cells
Yan, F. (2011) · uO Research (University of Ottawa) · doi:10.20381/ruor-6054
“PKC has been implicated in tumourigenesis (Griner and Kazanietz, 2007).”
Bingham, E. J. (2010) · University Library - University of Saskatchewan (University of Saskatchewan)
Kim, J., & Kazanietz, M. G. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_18
“Subsequently, PKCa, bII, d, and z have been shown to regulate angiogenesis in different cell types including corneal, vascular, and tumor endothelial cells (reviewed in (Griner and Kazanietz 2007)).”
BackgroundSelf-citationThe role of RalA and RalB in cancer
Falsetti, S. C. (2008) · Digital Commons - University of South Florida (University of South Florida)
Real, D. (2013) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/pews-km18
Newton, A. C. (2008)
PKC epsilon/PKC delta rate regulates human platelets production
Carubbi, C., Martini, S., Masselli, E., Galli, D., Bucci, G., Albanese, C., Mirandola, P., & Gobbi, G. (2015) · Italian Journal of Anatomy and Embryology · doi:10.36253/ijae-4050
Gomperts, B. D., Kramer, I. M., & Tatham, P. E. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369441-6.00019-2
Verma, A. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_15
“PKC isoforms exhibit functional diversity (Griner and Kazanietz 2007; Denning 2004; Aziz et al. 2006; Wheeler et al. 2004, 2005; Reddig et al. 1999, 2000; Jansen et al. 2001a, b). Disregulation of PKC activity has been associated with malignant transformation ( Griner and Kazanietz 2007; Basu and Sivaprasad 2007).”
BackgroundInfluentialProtein Kinase C and Lung Cancer
Xiao, L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_19
“There is growing evidence that the role of PKC in tumorigenesis is cell context-dependent and/or isoform-specific ( Griner and Kazanietz 2007 ).”
BackgroundHu, C., Wu, J., & Wu, W. (2010) · Cancer metastasis · doi:10.1007/978-90-481-9522-0_7
“Protein kinase C (PKC) family consist of the classical serine/threonine kinases that regulates a variety of cell functions including proliferation, differentiation, cytoskeletal organization, migration, and apoptosis [ 78 ].”
BackgroundPKC isozymes in the control of fate of prostate cancer cells
von Burstin (2011) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12702
Chemopreventive activity of tocopherols in mammary tumorigenesis
Smolarek, A. K. (2013) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3f47mtc
“PKC is correlated with a more aggressive phenotype in breast cancer [375].”
BackgroundVitamin D-mediated suppression of mammary tumorigenesis and mechanism of action
Lee, H. J. (2008) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3ng4qts
“Protein kinase C (PKC) The protein kinase C (PKC) family of serine/threonine kinases regulates cell growth, apoptosis, differentiation, cell migration and carcinogenesis in different types of cells [141,142].”
Regulation of SNARE proteins in macrophages by colony stimulating factor-1
Achuthan, A. A. (2007) · Minerva Access (University of Melbourne)
Efeito dual de FGF2 e PMA em células HEK 293 transformadas por H-rasV12
da Silva, J. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2014.tde-20012015-085930
Regulation of RhoA Activation and Actin Reorganization by Diacylglycerol Kinase
Ard, R. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-5554
Wang, Z., Tan, D., Cui, Y., & Yang, C. (2014)
Ischemia/reperfusion injury in the intestine : important roles for PKC, MAPK, and adenosine.
Jmv, M. (2011) · Europe PMC (PubMed Central)
Role of Protein Kinase C (PKC) Isoforms in Regulation of Filopodia Dynamics
Pandey, P. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Chung, C. (2016) · Deep Blue (University of Michigan)
Ibáñez, T. V. O. (2014) · TDX (Tesis Doctorals en Xarxa) · Cited by 1
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.